HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
KMTS
Kestra Medical Technologies Ltd
Healthcare Medical Instruments & Supplies · Washington, USA · Reports in usd
—
Market Cap: $1.49B
Market Cap
$1.49B
Enterprise Val
$1.37B
P/E Ratio
-9.96
P/B Ratio
6.71
Trailing PEG (1Y)
-0.20
As Of
Oct 13, 2026

Overview & Key Metrics

Reporting period: Jul 31, 2026 · Q1 2027
Book Value$222.4M
Gross Margin56.50%
Profit Margin56.50%
Return on Equity-64.18%
Return on Assets-45.01%
Current Ratio4.69
Debt/Equity0.34
LT Debt/Equity0.34
Revenue Per Share0.53

Income Statement

Jul 31, 2026
Revenue$31.0M
Cost of Revenue$13.5M
Gross Profit$17.5M
R&D$6.8M
SG&A$48.4M
Operating Expenses$55.2M
Operating Income-$37.7M
Interest Expense$1.9M
Tax Expense$50.0K
Net Income-$44.1M
EPS (Basic)$-0.75
EPS (Diluted)$-0.75
EBIT-$42.1M
EBITDA-$39.3M
Consolidated Income-$44.1M
Non-Controlling Interests$0.00

Balance Sheet

Jul 31, 2026
Cash & Equivalents$70.7M
Accounts Receivable$15.4M
Inventory$7.4M
Current Assets$226.3M
LT Investments$45.8M
Property, Plant & Equipment$66.9M
Intangibles$0.00
Non-Current Assets$121.1M
Total Assets$347.4M
Accounts Payable$26.0M
Current Debt$23.0K
Current Liabilities$48.3M
LT Debt$76.4M
Non-Current Liabilities$76.7M
Total Liabilities$125.0M
Total Debt$76.4M
Retained Earnings-$695.9M
Shareholder Equity$222.4M
Shares Outstanding58,602,497

Cash Flow Statement

Jul 31, 2026
Operating Cash Flow-$32.3M
Investing Cash Flow-$21.4M
Financing Cash Flow$22.5M
CapEx-$8.3M
Free Cash Flow-$40.6M
Depreciation & Amort.$2.8M
Stock-Based Comp$9.5M
Acquisitions / Disposals$0.00
Investment Activity-$13.0M
Debt Issued/Repaid$21.7M
Equity Issued/Repaid$2.0M
Dividends Paid$0.00
Net Change in Cash-$31.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h